The results of Oxford unicompartmental knee arthroplasty in the United States: a mean ten-year survival analysis

AIMS: Approved by the Food and Drug Administration in 2004, the Phase III Oxford Medial Partial Knee is used to treat anteromedial osteoarthritis (AMOA) in patients with an intact anterior cruciate ligament. This unicompartmental knee arthroplasty (UKA) is relatively new in the United States, and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Emerson, R. H., Alnachoukati, O., Barrington, J., Ennin, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Editorial Society of Bone and Joint Surgery 2016
Materias:
Knee
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047138/
https://www.ncbi.nlm.nih.gov/pubmed/27694514
http://dx.doi.org/10.1302/0301-620X.98B10.BJJ-2016-0480.R1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047138/
https://www.ncbi.nlm.nih.gov/pubmed/27694514
http://dx.doi.org/10.1302/0301-620X.98B10.BJJ-2016-0480.R1

Ejemplares similares